Postoperative radiochemotherapy in rectal cancer comparison of two combination schemes: Alternating versus concomitant

Tumori

Volumn 90, Issue 2, 2004, Pages 216-224

  Valencia, Javier ^a   Escó, Ricardo ^a   Polo, Sofía ^a   Bascón, Natividad ^a   Escudero, Pilar ^a   Alonso, Vícente ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

Combined modality therapy; Postoperative chemoradiation; Rectal cancer; Toxicity

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; CYSTITIS; DIARRHEA; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; INTESTINE SURGERY; IRRADIATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE PERIOD; RADIATION DOSE; RADIATION ENTEROPATHY; RADIOSENSITIZATION; RECTUM CANCER; SKIN MANIFESTATION; SMALL INTESTINE OBSTRUCTION; SURVIVAL RATE;

EID: 2942597893     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160409000210     Document Type: Article

References (43)

1. National Institute of Health Consensus Conference: Adjuvant therapy for patients with colon and rectal cancer. JAMA, 264: 1444-1449, 1990.
2. Glimelius B: Chemoradiotherapy for rectal cancer. Is there an optimal combination? Ann Oncol, 12: 1039-1045, 2001.
3. Bosset JF, Mantion G, Lorchel F, Magnin V, Pelissier EP, Gerard JP, Horiot JC: Adjuvant and neoadjuvant radiation therapy for rectal cancer. Semin Oncol, 27 (5 Suppl 10): 60-65, 2000.
4. Minsky BD: Adjuvant radiation therapy for rectal cancer: is there finally an answer? Lancet, 358: 1285-1286, 2001.
5. Swedish Rectal Cancer Trial: Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med, 336: 980-987, 1997.
6. a edición, pp 203-212, McGraw-Hill/Interamericana, Madrid, 1998.
7. Perry MC, Eaton WL, Propert KJ, Ware JH, Zimmer B, Chahinian AP, Skarin A, Carey RW, Kreisman H, Faulkner C: Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. N Engl J Med, 316: 912-918, 1987.
8. Pignon JP, Arriagada R, Idhe DC, Johnson DH, Perry MC, Souhami RL, Brodin O, Joss RA, Kies MS, Lebeau B: A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med, 327: 1618-1624, 1992.
9. Rubin P: Special issue: Late effects of normal tissues consensus conference, including RTOG/EORTC SOMA scales. Int J Radiat Oncol Biol Phys, 31: 1035-1360, 1995.
10. Miñarro R, Black RJ, Martínez C: Incidencia y mortalidad por cáncer en España. IARC Technical Report, 36: 24-26, 2000.
11. Gunderson LL, Sosin H: Areas of failure found at reoperation (second or symptomatic look) following curative surgery for adenocarcinoma of the rectum: clinicopathologic correlation and implications for adjuvant therapy. Cancer, 34: 1278-1292, 1974.
12. Rich T, Gunderson LL, Lew R, Galdibini JJ, Cohen AM, Donaldson G: Patterns of recurrence of rectal cancer after potentially curative surgery. Cancer, 52: 1317-1329, 1983.
13. Quirke P, Dixon MF, Durdey P, Williams NS: Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Lancet, 2: 996-999, 1986.
14. Adam IJ, Mohamdee MO, Martin IG, Scott N, Finan PJ, Johnston D, Dixon MF, Quirke P: Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet, 344: 707-711, 1994.
15. Soreide O, Norstein J: Local recurrence after operative treatment of rectal carcinoma: a strategy for change. J Am Coll Surg, 184: 84-92, 1997.
16. Enker WE, Thaler HT, Cranor ML, Polyak T: Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg, 181: 335-346, 1995.
17. Arbman G, Nilsson E, Hallbook O, Sjodahl R: Local recurrence following total mesorectal excision for rectal cancer. Br J Surg, 83: 375-379, 1996.
18. Kapiteijn E, Marijnen AM, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ: Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med, 345: 638-646, 2001.
19. Schild SE, Marterson JA Jr, Gunderson LL, Ilstrup DM, Berg KK, O'Connell MJ, Weiland LH: Postoperative adjuvant therapy of rectal cancer: an analysis of disease control, survival and prognostic factors. Int J Radiat Oncol Biol Phys, 17: 55-62, 1989.
20. Hoskins RB, Gunderson LL, Dorosetz DE, Rich TA, Galdabini J, Donaldson G, Cohen AM: Adjuvant postoperative radiotherapy in carcinoma of the rectum and rectosigmoid. Cancer, 55: 61-70, 1985.
21. Bentzen SM, Balslev I, Pedersen M, Teglbjaerg PS, Hanberg-Sorensen F, Bone J, Jacobsen NO, Sell A, Overgaard J, Bertelsen K: Time to loco-regional recurrence after resection of Dukes B and C colorectal cancer with or without adjuvant postoperative radiotherapy: a multivariate regression analysis. Br J Cancer, 65: 102-107, 1992.
22. Gastrointestinal Tumor Study Group: Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med, 312: 1465-1472, 1985.
23. Douglass HO Jr, Moertel CG, Mayer RJ, Thomas PR, Lindblad AS, Mittleman A, Stablein DM, Bruckner HW: Survival after postoperative combination treatment of rectal cancer [letter]. N Engl J Med, 315: 1294-1295, 1986.
24. Krook JE, Moertel CG, Gunderson LL, Wieand HS, Collins RT, Beart RW, Kubista TP, Poon MA, Meyers WC, Mailliard JA: Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med, 324: 709-715, 1991.
25. Fisher B, Wolmark N, Rockette H, Redmond C, Deutsch M, Wickerham DL, Fisher ER, Caplan R, Jones J, Lerner H: Postoperative adjuvant chemotherapy or radiation therapy por rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst, 80: 21-29, 1988.
26. Wolmark N, Wieand HS, Hyams DM, Colangelo L, Dimitrov NV, Romond EH, Wexler M, Prager D, Cruz AB Jr, Gordon PH, Petrelli NJ, Deutsch M, Mamounas E, Wickerham DL, Fisher ER, Rockette H, Fisher B: Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst, 92: 388-396, 2000.
27. Marijnen CAM, Nagtegaal ID, Kranenbarg EK, Hermans J, van de Velde CJ, Leer JW, van Krieken JH: Pathology Review Committee and the Cooperative Clinical Investigators. No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol, 19: 1976-1984, 2001.
28. Minsky BD: Adjuvant therapy for rectal cancer. A good first step. N Engl J Med, 336: 1016-1017, 1997.
29. Cammà C, Giunta M, Fiorica F, Pagliaro L, Craxi A, Cottone M: Preoperative radiotherapy for resectable rectal cancer. A meta-analysis. JAMA, 284: 1008-1015, 2000.
30. Colorectal Cancer Collaborative Group: Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials. Lancet, 358: 1291-1304, 2001.
31. Valentini V, Coco C, Cellini N, Picciocchi A, Rosetto ME, Mantini G, Marmiroli L, Barbaro B, Cogliandolo S, Nuzzo G, Tedesco M, Ambesi-Impiombato F, Cosimelli M, Rotman M: Preoperative chemoradiation with cisplatin and 5-fluorouracil for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, sphincter preservation. Int J Radiat Oncol Biol Phys, 45: 1175-1184, 1999.
32. Bosset JF, Magnin V, Maingon P, Mantion G, Pelissier EP, Mercier M, Chaillard G, Horiot JC: Preoperative radiochemotherapy in rectal cancer: long-term results of a phase II trial. Int J Radiat Oncol Biol Phys, 46: 323-327, 2000.
33. Grann A, Feng C, Wong D, Saltz L, Paty PP, Guillem JG, Cohen AM, Minsky BD: Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. Int J Radiat Oncol Biol Phys, 49: 987-995, 2001.
34. Rich TA, Skibber JM, Ajani JA, Buchholz DJ, Cleary KR, Dubrow RA, Levin B, Lynch PM, Meterissian SH, Roubein LD: Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys, 32: 1025-1029, 1995.
35. Russell AH, Harris J, Rosenberg PJ, Sause WT, Fisher BJ, Hoffman JP, Kraybill WG, Byhardt RW: Anal sphincter conservation for patients with adenocarcinoma of the distal rectum: long-term results of Radiation Therapy Oncology Group protocol 89-02. Int J Radiat Oncol Biol Phys, 46: 313-322, 2000.
36. Bosset JF, Horiot JC, Pavy JJ: Postoperative treatment of rectal cancer. In: Management of colorectal cancer, Bleiberg H, Rougier P, Wilke HJ (Eds), pp 345-349, Martin Dunitz, London, 1988.
37. Lupattelli M, Maranzano E, Bellavita R, Tarducci R, Latini R, Castagnoli P, Bufalari A, Corgna E, Pinaglia D, Rossetti R, Ribacchi R, Latini P: Adjuvant radiochemotherapy in high-risk rectal cancer results of prospective non-randomized study. Tumori, 87: 239-247, 2001.
38. Bertuccelli M, Cartei F, Falcone A, Campoccia S, Sainato A, Ducci F, Moda S, Pfanner E, Lencioni M, Brunetti I, Giulianotti PC, Mosca F, Laddaga M, Conte PF: Postoperative adjuvant chemoradiotherapy for rectal cancer: analysis of acute and chronic toxicity. Tumori, 83: 599-603, 1997.
39. O'Connell MJ, Martenson JA, Wieand HS, Krook JE, MacDonald JS, Haller DG, Mayer RJ, Gunderson LL, Rich TA: Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med, 331: 502-507, 1994.
40. Ma R, Phang PT: Results of curative surgery and postoperative chemoradiation for rectal adenocarcinoma in British Columbia, 1985 to 1994. Can J Surg, 44: 377-382, 2001.
41. Cabrera J, Montero MV, Muñoz JL, Mendicote F: Radioquimioterapia complementaria a cirugía radical en el adenocarcinoma de recto. Rev Oncología, 3: 79-84, 2001.
42. Escó R, Palacios A, Pardo J, Biete A, Carceller JA, Veiras C, Vazque G: Infrastructure of radiotherapy in Spain: a minimal standard of radiotherapy resources. Int J Radiat Oncol Biol Phys, 56: 319-327, 2003.
43. Ooi BS, Tjandra JJ, Green MD: Morbidities of adjuvant chemotherapy and radiotherapy for resectable rectal cancer: an overview. Dis Colon Rectum, 42: 403-418, 1999.